James B. Weissman, Chief Business Officer at Dicerna Pharmaceuticals Inc (DRNA), sold 29,360 shares at $13.07 ($384K) on 2019-08-23, disclosed to the SEC on 2019-08-23.
Open-market sale of $384k DRNA by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.07 | 14,680 | $192K | 50.0% |
| 2 | $13.07 | 14,680 | $192K | 50.0% |
| Total | $13.07 avg | 29,360 | $384K | 100% |
| Filing → |
| DRNA | SELL | 2021-02-08 | $386K | — | Filing → |
| DRNA | SELL | 2021-01-12 | $91K | — | Filing → |
| DRNA | SELL | 2020-12-03 | $220K | — | Filing → |